The Next-Generation Biomanufacturing Market is transforming the way biological products are developed and manufactured. It brings together advanced approaches such as synthetic biology, microbial biomanufacturing, cell-free systems, continuous bioprocessing, automation, and digital technologies to make production more efficient, scalable, and sustainable.
These technologies are increasingly important for producing biopharmaceuticals, vaccines, enzymes, amino acids, and other biological products. As demand for biologic medicines continues to increase, manufacturers are looking for flexible production platforms that can improve productivity while maintaining quality and reducing operational complexity.
Market Size and Growth
According to Market Research Future, the global Next-Generation Biomanufacturing Market was valued at approximately USD 30.66 billion in 2024 and is projected to reach around USD 86.63 billion by 2035, expanding at a CAGR of 9.9% from 2025 to 2035. North America accounted for more than 45% of the market in 2024.
Get Free Sample PDF Brochure:
https://www.marketresearchfuture.com/sample_request/21984
Market Drivers
Growing Demand for Biopharmaceuticals
The increasing use of biologic medicines, vaccines, recombinant proteins, and other advanced therapies is creating a strong need for modern manufacturing capabilities. Next-generation production platforms can help manufacturers respond to growing demand while improving production efficiency and scalability.
Advances in Synthetic Biology
Synthetic biology is opening new possibilities for designing biological systems that can produce valuable molecules more efficiently. Improvements in genetic engineering, cell engineering, and biological process design are supporting the development of more productive and adaptable manufacturing systems.
Increasing Adoption of Automation and Digital Technologies
Automation, advanced analytics, artificial intelligence, and digital process monitoring are becoming increasingly important in biomanufacturing. These technologies can help manufacturers monitor production conditions, optimize processes, improve consistency, and identify potential issues earlier.
Shift Toward Sustainable Manufacturing
Sustainability is becoming a major consideration across the biotechnology industry. Next-generation biomanufacturing can support more efficient use of raw materials, energy, water, and production space. Continuous processing, microbial platforms, and other advanced technologies are helping manufacturers explore more sustainable production models.
Expansion of Flexible and Scalable Production
The need for manufacturing systems that can adapt to changing product requirements is increasing. Modular facilities, continuous processing, and advanced bioprocessing platforms can provide manufacturers with greater flexibility when scaling production from research and development to commercial manufacturing.
Market Challenges
High Investment Requirements
Implementing advanced biomanufacturing platforms can require substantial investment in equipment, facilities, software, skilled personnel, and regulatory compliance. These costs can make adoption more challenging for smaller organizations and manufacturers operating in developing markets.
Technical Complexity
Next-generation manufacturing processes often involve sophisticated biological systems, automation platforms, analytics, and process-control technologies. Integrating these components effectively requires specialized technical expertise and experienced personnel.
Regulatory Complexity
Biological manufacturing processes must meet strict quality, safety, and regulatory requirements. As technologies such as continuous processing, synthetic biology, and digitally enabled manufacturing evolve, manufacturers may need to navigate changing regulatory expectations.
Limited Access to Specialized Infrastructure
Advanced biomanufacturing capabilities are not equally available across all regions. Differences in infrastructure, technical expertise, investment capacity, and access to specialized facilities can slow adoption in emerging markets.
Process Scale-Up Challenges
Moving from laboratory-scale development to commercial production can introduce challenges related to process consistency, yield, quality control, and cost efficiency. Manufacturers must carefully optimize processes before large-scale implementation.
Browse In-depth Market Research Report on Next-Generation Biomanufacturing Market
Market Segmentation
By Technology:
Synthetic Biology:
Synthetic biology uses engineered biological systems to develop new production pathways and improve the output of valuable biological products.
Cell-Free Systems:
Cell-free manufacturing platforms produce biological molecules without relying on intact living cells, offering potential advantages in flexibility and process control.
Microbial Biomanufacturing:
Microbial systems are widely used to produce enzymes, amino acids, pharmaceuticals, and other biological products. MRFR identifies microbial biomanufacturing as the leading technology segment in 2024, with a share of approximately 54%.
Continuous Bioprocessing:
Continuous manufacturing allows production processes to operate with fewer interruptions, potentially improving productivity, process control, and manufacturing efficiency.
By Application:
Pharmaceuticals:
Biomanufacturing technologies play an important role in producing biologics, vaccines, therapeutic proteins, and other pharmaceutical products.
Food and Beverage:
Advanced biological production methods are used to develop enzymes, ingredients, proteins, and other products for the food and beverage industry.
Biofuels:
Biological manufacturing platforms can support the development of alternative fuels and renewable energy products.
Bioplastics:
Next-generation biotechnology is being explored to produce sustainable alternatives to conventional petroleum-based plastics.
By End Use:
Industrial:
Industrial organizations use biomanufacturing technologies to produce enzymes, specialty chemicals, biomaterials, and other commercially valuable products.
Research and Development:
Research institutions and biotechnology organizations use advanced platforms to develop new biological products and optimize production processes.
Commercial:
Commercial manufacturers apply next-generation technologies to scale biological products for broader market distribution.
By Product Type:
Enzymes:
Enzymes are widely used across pharmaceutical, food, industrial, and biotechnology applications. MRFR reports enzymes as a rapidly growing product category.
Amino Acids:
Advanced biological production methods can improve the scalable manufacturing of amino acids for pharmaceutical, food, and industrial applications.
Vaccines:
Modern biomanufacturing technologies support the development and large-scale production of different vaccine platforms.
Biopharmaceuticals:
Biopharmaceutical manufacturing represents a major application area as demand increases for biologic medicines and advanced therapeutic products.
By Region:
North America:
North America represents a major regional market, supported by established biotechnology infrastructure, strong research activity, significant biopharmaceutical production, and adoption of advanced manufacturing technologies.
Europe:
Europe has a well-developed biotechnology and pharmaceutical ecosystem, with growing interest in sustainable manufacturing, process automation, and advanced bioprocessing.
Asia-Pacific:
Asia-Pacific is experiencing increasing investment in biotechnology, pharmaceutical manufacturing, and advanced production infrastructure. Growing demand for biopharmaceutical products is also creating opportunities for next-generation manufacturing technologies.
South America, Middle East & Africa:
These regions represent developing opportunities as healthcare infrastructure, biotechnology investment, pharmaceutical production, and access to advanced manufacturing technologies continue to improve.
Regional Insights
North America
North America held the largest regional share of the market in 2024, accounting for more than 45% of global revenue. Strong biopharmaceutical manufacturing capabilities, research infrastructure, technology adoption, and investment in advanced biotechnology are supporting regional growth.
Europe
Europe remains an important market for next-generation biomanufacturing. The region benefits from established pharmaceutical and biotechnology industries, research capabilities, and growing attention to sustainable and efficient production. MRFR estimates the European market at approximately USD 9.20 billion in 2024.
Asia-Pacific
Asia-Pacific is developing into an increasingly important market as biotechnology investments expand and pharmaceutical manufacturers adopt advanced production technologies. Growing healthcare demand and increasing biopharmaceutical manufacturing capacity are creating additional opportunities across countries such as China, Japan, India, and South Korea.
Rest of the World
Latin America, the Middle East, and Africa are expected to present additional opportunities as healthcare systems develop, pharmaceutical manufacturing expands, and investment in biotechnology infrastructure increases.
Key Players
Amgen
Genentech
Bayer
Novartis
GSK
Merck KGaA
Regeneron Pharmaceuticals
Sartorius
Lonza
These companies are among the major participants identified by MRFR in the global Next-Generation Biomanufacturing Market.
Future Outlook
The Next-Generation Biomanufacturing Market is expected to continue expanding as biotechnology companies and pharmaceutical manufacturers adopt more efficient, flexible, and digitally connected production systems.
According to MRFR, the market is projected to reach approximately USD 86.63 billion by 2035, with a 9.9% CAGR between 2025 and 2035.
Future opportunities are expected to come from the development of modular manufacturing facilities, AI-enabled process optimization, advanced synthetic biology, continuous bioprocessing, and personalized medicine. These developments could help manufacturers improve scalability, production efficiency, quality control, and resource utilization.
As the biopharmaceutical industry continues to evolve, next-generation biomanufacturing is likely to become increasingly important in supporting the reliable and sustainable production of complex biological products.
Related Reports:
Orthopedic Software Market Research Report – Global Forecast 2032
Peptide Microarray Market Research Report – Global Forecast 2032
Photomedicine Devices and Technologies Market Research Report – Global Forecast 2032
Cardiac AI Monitoring and Diagnostics Market Research Report – Global Forecast 2032
Ciclopirox Market Research Report – Global Forecast 2032
Cryptococcosis Market Research Report – Global Forecast 2032
Healthcare PMMA Market Research Report – Global Forecast 2032
Tablet Hardness Testers Market Research Report – Global Forecast 2032
About Market Research Future
Market Research Future (MRFR) is a global market research company providing market intelligence and research services across a wide range of industries. Its research covers markets at global, regional, and country levels, with analysis organized around products, technologies, applications, end users, and key market participants.
MRFR’s research aims to provide businesses and decision-makers with detailed market information that can support strategic planning and help identify emerging opportunities.
Website: https://www.marketresearchfuture.com
